跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 19,938 条关于
“P2Y12 inhibitor”
全部
19,938
临床试验
9,796
药物
4,066
机构
20
资讯
6,056
2个月前
CureGene Doses First Participant in U.S. Pivotal Trial of Evategrel, a Novel Dual-Formulation P2Y12 Inhibitor
去年
P2Y12 Inhibitors Show 23% Reduction in Cardiovascular Events Compared to Aspirin in Post-Stent Patients
7个月前
Concept Medical Initiates Global STARS DAPT Trial for Polymer-Free Drug-Eluting Stent in STEMI Patients
去年
Shorter Dual Antiplatelet Therapy Shows Promise in Heart Attack Patients: Two Major Trials Challenge Current Guidelines
去年
Genomadix and Mayo Clinic Collaborate on Precision Medicine for Telestroke via Rapid CYP2C19 Genotyping
去年
Bayer Advances Asundexian to Phase 3 Despite Phase 2 Efficacy Misses
去年
Bentracimab Shows Promising Results in Phase 3 Trial for Reversing Ticagrelor's Antiplatelet Effects
10个月前
Shortened Dual Anticoagulation Therapy After Stent Placement Shows Equal Efficacy with Reduced Bleeding Risk in AFib Patients
10个月前
TUXEDO-2 Trial Shows Prasugrel Outperforms Ticagrelor in Diabetic Patients After Stent Placement
去年
Alembic Pharmaceuticals Receives FDA Approval for Generic Ticagrelor Tablets to Reduce Cardiovascular Risks
第 1 页,共 606 页
上一页
下一页